Eli Lilly Current Deferred Revenue (Quarterly) Trends

Eli Lilly & Co. (LLY)

1065.22 -22.16 (-2.04%) USD | NYSE | Jan 23, 16:00

1065.01 -0.21 (-0.02%) After-Hours: 18:24

View Current Deferred Revenue (Quarterly) for LLY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Adverum Biotechnologies, Inc.	--
Viking Therapeutics, Inc.	--
Moderna, Inc.	Upgrade